US EditionFDA's Top Drug Regulator Resigns After Federal Officials Probe 'Serious Concerns'
- Dr. George Tidmarsh, leading drug regulator at the U.S. Food and Drug Administration's Center for Drug Evaluation and Research , was placed on leave Friday after the Department of Health and Human Services Office of General Counsel was notified; he resigned Sunday.
- Aurinia Pharmaceuticals sued, alleging Tidmarsh accepted bribes and defamed a former colleague during his FDA tenure and used his post to pursue a vendetta against Kevin Tang in U.S. District Court of Maryland.
- Aurinia says Tidmarsh's LinkedIn post claiming voclosporin lacked proven benefit caused a 20% stock decline, wiping out over $350 million, and he later deleted it, saying it was in his personal capacity.
- HHS said its Office of General Counsel was alerted, leading to Tidmarsh's leave, while the FDA's Center for Drug Evaluation and Research lost more than 1,000 staffers over the past year.
- Tidmarsh's departure follows months of firings and departures at the FDA; the center he led, CDER, is the agency's largest division responsible for medicine review and safety.
72 Articles
72 Articles
FDA’s drug division chief resigns amid ethics concerns, lawsuit | Honolulu Star-Advertiser
The director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of Health and Human Services spokesperson told Reuters on Monday.
FDA’s top drug regulator sued by drug company, resigns amid conduct probe
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused of using his position of authority to publicly denigrate a treatment tied to a former business associate. Dr. George Tidmarsh, a drug industry veteran who joined the administration in July, was placed on administrative leave Friday…
FDA’s Top Drug Regulator Has Resigned, Health Department Says
A top Food and Drug Administration official has resigned, according to the Department of Health and Human Services. Dr. George Tidmarsh, director of the FDA’s Center for Drug Evaluation and Research since July, stepped down on Nov. 2, a spokesperson for the department headed by Health Secretary Robert F. Kennedy Jr. said. Tidmarsh’s resignation came several days after he was placed on leave following officials at the department learning of “seri…
Coverage Details
Bias Distribution
- 66% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
